Using Lumit™ Technology to Address Inflammasome-mediated Cytokine Release
This webinar is Part 2 of the Lumit™ Technology Webinar Series.
In this webinar, you will learn:
- How to detect human or mouse IL-1ß with no sample transfer or wash steps using Lumit™ technology
- How the Lumit™ technology has enabled specific detection of active IL-1ß
- How Lumit™ cytokine assays can be combined with other inflammasome assays to identify and rank the potency of inflammasome inhibitors
Summary
Lumit™ Technology Webinar Series
Immunoassays are an essential tool for life science researchers, widely used for decades. Applying bioluminescent technology to this well-accepted assay format to create Lumit™ Immunoassays has made analyte detection faster and easier than ever before. This webinar series will introduce you to Lumit™ Immunoassay technology and highlight key research areas where bioluminescent immunoassays have supported research discoveries.
Part 2: Using Lumit™ Technology to Address Inflammasome-mediated Cytokine Release
In the second part of this series, Drs. Martha O’Brien, Promega, will dive into inflammasome research. Learn how simplifying cytokine detection from cultured cells supports inflammasome research.
Other Webinars in this Series:
Bioluminescent Analyte Detection with Lumit™ Immunoassays
Ask the Experts Forum: Implementing Lumit™ Immunoassays
Advances in Glucagon Detection Supporting Diabetes and Metabolic Disorder Research
Speaker
Martha O'Brien, PhD
Senior Research Scientist
Martha O’Brien is a Senior Research Scientist in the Assay Design Group in R&D at Promega and is currently leading assay development efforts focused on inflammation and the inflammasome. Martha received her PhD in biology from the University of North Carolina and postdoctoral training at Washington University in St. Louis. As a long-term Promega R&D scientist, she has developed numerous products applying bioluminescence technology to cell health, protease assays, and studying the inflammasome.